stage iv esophageal cancer
Showing 1 - 16 of 16
Stage IV Gastric Cancer, Stage IIIA Gastric Cancer, Stage IIIB Gastric Cancer Trial (basic nutrition, oral supplement of
Not yet recruiting
- Stage IV Gastric Cancer
- +4 more
- basic nutrition
- oral supplement of creatine and curcumin
- (no location specified)
May 16, 2023
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in
Terminated
- Adenocarcinoma of the Esophagus
- +13 more
- oblimersen sodium
- +2 more
-
Bronx, New YorkMontefiore Medical Center
Jan 29, 2021
Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in Canada, United
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +6 more
-
Dalton, Georgia
- +4 more
Jul 26, 2018
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in
Withdrawn
- Adenocarcinoma of the Esophagus
- +13 more
- c-Met inhibitor AMG 337
- +6 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Oct 17, 2017
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in
Completed
- Adenocarcinoma of the Esophagus
- +8 more
- fluorouracil
- +6 more
-
Duarte, California
- +2 more
Apr 26, 2017
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)
Completed
- Anaplastic Astrocytoma
- +64 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2016
Adenocarcinoma of the Esophagus, Adenocarcinomas of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in Columbus
Completed
- Adenocarcinoma of the Esophagus
- +4 more
- pralatrexate
- +3 more
-
Columbus, OhioOhio State University
Apr 25, 2016
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,
Completed
- Adenocarcinoma of the Colon
- +66 more
- cetuximab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 28, 2015
Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer Trial in
Completed
- Advanced Adult Primary Liver Cancer
- +87 more
- 7-hydroxystaurosporine
- +2 more
-
Charlottesville, VirginiaUniversity of Virginia
Sep 27, 2013
Adenocarcinoma of the Gastroesophageal Junction, HER2-positive Breast Cancer, Male Breast Cancer Trial in New York (drug,
Terminated
- Adenocarcinoma of the Gastroesophageal Junction
- +11 more
- Akt inhibitor MK2206
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Sep 27, 2013
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer Trial in New York
Completed
- Adenocarcinoma of the Esophagus
- +5 more
- erlotinib hydrochloride
- laboratory biomarker analysis
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 3, 2013
Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,
Completed
- Advanced Adult Primary Liver Cancer
- +126 more
- recombinant interleukin-12
- ABI-007/carboplatin/trastuzumab
-
Columbus, OhioOhio State University Medical Center
Feb 27, 2013
Adenocarcinoma of the Esophagus, Stage III Esophageal Cancer, Stage IV Esophageal Cancer Trial in Houston (arsenic trioxide)
Terminated
- Adenocarcinoma of the Esophagus
- +2 more
- arsenic trioxide
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Chicago (erlotinib HCl,
Completed
- Adult Anaplastic Astrocytoma
- +85 more
- erlotinib hydrochloride
- laboratory biomarker analysis
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 15, 2013